Advertisement

Inpharma Weekly

, Volume 1628, Issue 1, pp 18–18 | Cite as

New Drug Application granted priority review for difluprednate in US.

Media release
  • 3 Downloads

Keywords

Medium Release Drug Application Ocular Inflammation Priority Review Grant Priority Review 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2008

Personalised recommendations